Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
Rajagopal L, Masse BW, Huang M, Oyamada Y, Meltzer HY
[1] [3] Clinical trials have examined the incidence of various cancer types in patients receiving GLP-1-based therapies
Glutathione Injection Cost in Chennai: What You Should Expect How Much Does Glutathione Injection Cost
Overconsumption of caffeine: Excess caffeine can stimulate cortisol production